PALLIARE
DEAD

Serial Number

85213907

Owner

JANISYS LIMITED

Attorney

LEIGH ANN LINDQUIST

Filing Date

Jan 10, 2011

Add to watchlist:

No watchlists yet
View on USPTO

PALLIARE Trademark

Serial Number: 85213907 • Registration: 4188810

PALLIARE is a trademark filed by JANISYS LIMITED on January 10, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

JANISYS LIMITED (4 trademarks)

Galway Business Park
Dangan, Galway , IE

Entity Type: 99

Trademark Details

Filing Date

January 10, 2011

Registration Date

August 14, 2012

Published for Opposition

May 29, 2012

Cancellation Date

March 15, 2019

Goods & Services

Medical and veterinary delivery apparatus, equipment, instruments, devices and systems, namely, drug delivery agents in the form of tablets, powders, capsules, pills, caplets, liquid drops and sachets that provide controlled release of active ingredients for a wide variety of medicaments, pharmaceuticals, vaccines and drugs for delivery thereof intradermally, transdermally, subcutaneously or otherwise through the skin; transdermal patches for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal and dermatological diseases and disorders, immune system related diseases and disorders, cancer, autoimmune diseases and disorders, diabetes, kidney diseases and disorders, ocular diseases and disorders, bacteria-based diseases and disorders, influenza, psychiatric diseases and disorders, voice disorders, digestive disorders, vulvovaginal disorders, congenital disorders, depression, eating disorders, anorexia, obesity, infectious diseases and bone diseases containing medicaments, pharmaceuticals, vaccines and drugs for delivery thereof intradermally, transdermally, subcutaneously or otherwise through the skin; micro-needle devices, namely, active transdermal micro-needle drug delivery patches for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal and dermatological diseases and disorders, immune system related diseases and disorders, cancer, autoimmune diseases and disorders, diabetes, kidney diseases and disorders, ocular diseases and disorders, bacteria-based diseases and disorders, influenza, psychiatric diseases and disorders, voice disorders, digestive disorders, vulvovaginal disorders, congenital disorders, depression, eating disorders, anorexia, obesity, infectious diseases and bone diseases containing medicaments, pharmaceuticals, vaccines and drugs intradermally, transdermally, subcutaneously or otherwise through the skin; cartridges sold pre-filled with medicaments, pharmaceuticals, vaccines and drugs for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal and dermatological diseases and disorders, immune system related diseases and disorders, cancer, autoimmune diseases and disorders, diabetes, kidney diseases and disorders, ocular diseases and disorders, bacteria-based diseases and disorders, influenza, psychiatric diseases and disorders, voice disorders, digestive disorders, vulvovaginal disorders, congenital disorders, depression, eating disorders, anorexia, obesity, infectious diseases and bone diseases used in medical and veterinary delivery apparatus, equipment, instruments, devices and systems; and cartridges sold pre-filled with medicaments, pharmaceuticals, vaccines and drugs for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal and dermatological diseases and disorders, immune system related diseases and disorders, cancer, autoimmune diseases and disorders, diabetes, kidney diseases and disorders, ocular diseases and disorders, bacteria-based diseases and disorders, influenza, psychiatric diseases and disorders, voice disorders, digestive disorders, vulvovaginal disorders, congenital disorders, depression, eating disorders, anorexia, obesity, infectious diseases and bone diseases used in micro-needle devices; preparations for use in dialysis, namely, pharmaceutical solutions used in dialysis

Medical and veterinary apparatus, equipment, instruments and devices, namely, micro-needles for medical use; transdermal drug delivery patches sold without medication; medical and veterinary delivery apparatus, equipment, instruments, devices and systems, namely, drug delivery patches sold without medication, electronic-kinetic transdermal drug delivery control unit for the treatment of diseases for delivering medicaments, pharmaceuticals, vaccines and other substances intradermally, transdermally, subcutaneously or otherwise through the skin; medical and veterinary apparatus, equipment, instruments, devices and systems, namely, micro-needles for medical use, medical needles and introducers, drainage tubes for medical purposes and wound suction apparatus for withdrawing bodily substances intradermally, transdermally, subcutaneously or otherwise through the skin; drug delivery patches sold without medication for delivering medicaments, pharmaceuticals, vaccines and other substances intradermally, transdermally, subcutaneously or otherwise through the skin; micro-needle devices, namely, active transdermal micro-needle drug delivery patches sold without medication for the treatment of diseases for delivering medicaments, pharmaceuticals, vaccines and other substances intradermally, transdermally, subcutaneously or otherwise through the skin; micro-needle devices, namely, active transdermal micro-needle drug delivery patches sold without medication for the treatment of diseases for withdrawing bodily substances intradermally, transdermally, subcutaneously or otherwise through the skin; micro-needles for delivering medicaments, pharmaceuticals, vaccines and other substances intradermally, transdermally, subcutaneously or otherwise through the skin; micro-needles for withdrawing bodily substances intradermally, transdermally, subcutaneously or otherwise through the skin; micro-needle pads, namely, transdermal micro-needle arrays for delivering medicaments, pharmaceuticals, vaccines and other substances intradermally, transdermally, subcutaneously or otherwise through the skin; micro-needle elements, namely, needle-free injection systems, needle-based injection systems and injection instruments with needles for use in such micro-needle devices; cartridges sold empty specially designed for holding medicaments, pharmaceuticals, vaccines and drugs for use in medical and veterinary delivery apparatus, equipment, instruments, devices and systems; cartridges sold empty specially designed for holding medicaments, pharmaceuticals, vaccines and drugs used in micro-needle devices; needles for medical and veterinary purposes; diagnostic apparatus, equipment, instruments, devices and systems, namely, blood pressure monitors, hematology analyzers for medical diagnostic uses and haemostats for medical and veterinary purposes; dialysis machines for medical use

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 15, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 14, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 14, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2012 NPUB
PUBLISHED FOR OPPOSITION
May 29, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2012 NONP
ASSIGNED TO EXAMINER
May 4, 2012 DOCK
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 21, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 1, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 1, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 1, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 1, 2012 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2011 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2011 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 17, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 3, 2011 GNRN
NON-FINAL ACTION E-MAILED
Nov 3, 2011 GNRT
NON-FINAL ACTION WRITTEN
Nov 3, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 6, 2011 GNRN
NON-FINAL ACTION E-MAILED
Apr 6, 2011 GNRT
NON-FINAL ACTION WRITTEN
Apr 6, 2011 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2011 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 3, 2011 AMPX
ASSIGNED TO LIE
Mar 3, 2011 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 22, 2011 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2011 NWOS
NEW APPLICATION ENTERED
Jan 13, 2011 NWAP